Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.
暂无分享，去创建一个
E. Wardelmann | F. Chibon | P. Lagarde | J. Coindre | A. Italiano | P. Rutkowski | M. Debiec‐Rychter | L. Lartigue | A. Neuville | C. Brulard | P. Dei Tos